NASDAQ:MBOT - Microbot Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.9199 -0.03 (-3.16 %)
(As of 05/28/2018 01:15 AM ET)
Previous Close$0.9199
Today's Range$0.90 - $0.9778
52-Week Range$0.58 - $6.00
Volume598,333 shs
Average Volume474,608 shs
Market Capitalization$38.75 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.07

About Microbot Medical (NASDAQ:MBOT)

Microbot Medical logoMicrobot Medical Inc., a pre-clinical medical device company, researches, designs, and develops next generation micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company's product candidates include Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and TipCAT, a semi-disposable, flexible, and self-propelled endoscope for use in colonoscopy procedures, as well as ViRob, a revolutionary autonomous crawling micro-robot technology, which can be controlled remotely or within the body. Microbot Medical Inc. was founded in 2010 and is based in Yokneam, Israel.

Receive MBOT News and Ratings via Email

Sign-up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:MBOT
CUSIPN/A
Phone781-875-3605

Debt

Debt-to-Equity RatioN/A
Current Ratio21.04
Quick Ratio21.04

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$120,000.00
Price / Sales322.88
Cash FlowN/A
Price / CashN/A
Book Value$0.22 per share
Price / Book4.18

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-7,580,000.00
Net MarginsN/A
Return on Equity-48.95%
Return on Assets-46.46%

Miscellaneous

Employees7
Outstanding Shares42,120,000

Microbot Medical (NASDAQ:MBOT) Frequently Asked Questions

What is Microbot Medical's stock symbol?

Microbot Medical trades on the NASDAQ under the ticker symbol "MBOT."

When did Microbot Medical's stock split? How did Microbot Medical's stock split work?

Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of Microbot Medical stock prior to the reverse split would have 8 shares after the split.

How were Microbot Medical's earnings last quarter?

Microbot Medical (NASDAQ:MBOT) announced its quarterly earnings data on Tuesday, May, 15th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.04) by $0.01. View Microbot Medical's Earnings History.

When is Microbot Medical's next earnings date?

Microbot Medical is scheduled to release their next quarterly earnings announcement on Monday, May, 28th 2018. View Earnings Estimates for Microbot Medical.

What price target have analysts set for MBOT?

1 brokers have issued twelve-month target prices for Microbot Medical's shares. Their forecasts range from $1.75 to $1.75. On average, they expect Microbot Medical's stock price to reach $1.75 in the next twelve months. View Analyst Ratings for Microbot Medical.

Who are some of Microbot Medical's key competitors?

Who are Microbot Medical's key executives?

Microbot Medical's management team includes the folowing people:
  • Mr. Harel Gadot, Co-Founder, Pres, CEO & Chairman (Age 45)
  • Prof. Moshe Shoham D.Sc., Co-Founder, Scientific Director & Member of Scientific Advisory Board (Age 66)
  • Mr. Yoseph Bornstein, Co-Founder & Director (Age 59)
  • Mr. Yehezkel Himelfarb BSc, MBA, COO, GM & Director (Age 60)
  • Dr. Simon Sharon, Chief Technology Officer

Has Microbot Medical been receiving favorable news coverage?

Headlines about MBOT stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Microbot Medical earned a daily sentiment score of 0.18 on Accern's scale. They also gave news articles about the biotechnology company an impact score of 45.33 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Microbot Medical?

Shares of MBOT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Microbot Medical's stock price today?

One share of MBOT stock can currently be purchased for approximately $0.9199.

How big of a company is Microbot Medical?

Microbot Medical has a market capitalization of $38.75 million and generates $120,000.00 in revenue each year. Microbot Medical employs 7 workers across the globe.

How can I contact Microbot Medical?

Microbot Medical's mailing address is 25 RECREATION PARK DRIVE UNIT 108, HINGHAM MA, 02043. The biotechnology company can be reached via phone at 781-875-3605 or via email at [email protected]


MarketBeat Community Rating for Microbot Medical (MBOT)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  148 (Vote Underperform)
Total Votes:  362
MarketBeat's community ratings are surveys of what our community members think about Microbot Medical and other stocks. Vote "Outperform" if you believe MBOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MBOT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Microbot Medical (NASDAQ:MBOT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for Microbot Medical in the last 12 months. Their average twelve-month price target is $1.75, suggesting that the stock has a possible upside of 90.24%. The high price target for MBOT is $1.75 and the low price target for MBOT is $1.75. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $1.75$1.75$1.75N/A
Price Target Upside: 90.24% upside66.67% upside66.67% upsideN/A

Microbot Medical (NASDAQ:MBOT) Consensus Price Target History

Price Target History for Microbot Medical (NASDAQ:MBOT)

Microbot Medical (NASDAQ:MBOT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/31/2018Ladenburg ThalmannInitiated CoverageBuy ➝ Buy$1.75LowView Rating Details
11/18/2016S&P Equity ResearchLower Price Target$1.36 ➝ $1.15N/AView Rating Details
5/31/2016Maxim GroupDowngradeBuy ➝ HoldN/AView Rating Details
(Data available from 5/28/2016 forward)

Earnings

Microbot Medical (NASDAQ:MBOT) Earnings History and Estimates Chart

Earnings by Quarter for Microbot Medical (NASDAQ:MBOT)

Microbot Medical (NASDAQ:MBOT) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.16 EPS
Next Year EPS Consensus Estimate: $-0.17 EPS

Microbot Medical (NASDAQ MBOT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/28/2018        
5/15/2018Q1 2018($0.04)($0.03)ViewN/AView Earnings Details
8/14/2017Q2 2017($0.48)($0.04)ViewN/AView Earnings Details
5/15/2017Q1 2017($0.48)($0.04)ViewN/AView Earnings Details
8/15/2016Q2 2016($3.87)$0.03 millionViewN/AView Earnings Details
5/10/2016Q1 2016($8.82)$0.02 millionViewN/AView Earnings Details
3/23/2016Q4($0.09)($0.07)$0.04 million$0.03 millionViewListenView Earnings Details
11/2/2015Q3 2015($0.10)($0.09)$0.04 millionViewN/AView Earnings Details
8/6/2015Q215($0.09)($0.10)$0.03 million$0.03 millionViewListenView Earnings Details
5/5/2015Q1 2015($14.05)$0.02 millionViewN/AView Earnings Details
3/16/2015Q4($0.12)($0.14)$220.00 million$883.00 millionViewListenView Earnings Details
11/5/2014Q3 2014($0.13)($0.11)$0.30 million$0.27 millionViewN/AView Earnings Details
8/12/2014Q2($0.14)($0.15)$0.30 million$0.24 millionViewListenView Earnings Details
5/14/2014Q1($0.12)($0.14)$0.24 million$0.3390 millionViewListenView Earnings Details
3/12/2014Q4($0.13)($0.13)$0.22 million$0.3120 millionViewListenView Earnings Details
11/5/2013Q3 2013($18.37)$0.33 millionViewN/AView Earnings Details
8/7/2013Q2 2013($16.21)$0.28 millionViewN/AView Earnings Details
5/9/2013Q113($0.13)($0.17)$0.29 million$0.2840 millionViewListenView Earnings Details
3/21/2013Q412($0.14)($0.07)$0.31 million$0.2110 millionViewListenView Earnings Details
11/8/2012Q3 2012($21.61)($18.37)ViewN/AView Earnings Details
8/2/2012Q2 2012($27.01)$3.67ViewN/AView Earnings Details
5/10/2012Q1 2012($30.26)($24.85)ViewN/AView Earnings Details
3/13/2012Q4 2011($38.90)($46.46)ViewN/AView Earnings Details
11/1/2011Q3 2011($47.54)($46.03)ViewN/AView Earnings Details
7/28/2011Q2 2011($54.03)($31.55)ViewN/AView Earnings Details
5/4/2011Q1 2011($64.83)($45.38)ViewN/AView Earnings Details
3/11/2011Q4 2010($54.03)($84.28)ViewN/AView Earnings Details
11/3/2010Q3 2010($75.64)($47.54)ViewN/AView Earnings Details
8/10/2010Q2 2010($86.44)($41.06)ViewN/AView Earnings Details
5/4/2010Q1 2010($75.64)($55.11)ViewN/AView Earnings Details
3/11/2010Q4 2009($49.70)ViewN/AView Earnings Details
11/5/2009Q3 2009($51.87)ViewN/AView Earnings Details
8/10/2009Q2 2009($75.64)ViewN/AView Earnings Details
5/8/2009Q1 2009($104.81)ViewN/AView Earnings Details
3/16/2009Q4 2008($86.44)ViewN/AView Earnings Details
11/4/2008Q3 2008($76.72)ViewN/AView Earnings Details
8/5/2008Q2 2008($89.68)ViewN/AView Earnings Details
5/6/2008Q1 2008($95.09)ViewN/AView Earnings Details
3/14/2008Q4 2007($104.81)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Microbot Medical (NASDAQ:MBOT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Microbot Medical (NASDAQ MBOT) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 31.83%
Institutional Ownership Percentage: 5.06%
Insider Trading History for Microbot Medical (NASDAQ:MBOT)

Microbot Medical (NASDAQ MBOT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2018Yoseph BornsteinDirectorSell35,000$1.06$37,100.00View SEC Filing  
1/2/2018Yoseph BornsteinDirectorSell42,132$1.01$42,553.32View SEC Filing  
12/27/2017Yoseph BornsteinDirectorSell14,257$1.02$14,542.14View SEC Filing  
12/19/2017Yoseph BornsteinDirectorSell32,067$1.03$33,029.01View SEC Filing  
12/12/2017Yoseph BornsteinDirectorSell44,159$1.04$45,925.36View SEC Filing  
12/6/2017Yoseph BornsteinDirectorSell15,375$1.05$16,143.75View SEC Filing  
12/4/2017Yoav Zvi WaizerDirectorBuy10,000$1.10$11,000.0010,000View SEC Filing  
11/28/2017Yoseph BornsteinDirectorSell45,000$1.07$48,150.00View SEC Filing  
11/21/2017Yoseph BornsteinDirectorSell45,000$1.21$54,450.00View SEC Filing  
10/24/2017Yoseph BornsteinDirectorSell50,000$1.14$57,000.00View SEC Filing  
10/17/2017Yoseph BornsteinDirectorSell50,000$1.16$58,000.00View SEC Filing  
10/10/2017Yoseph BornsteinDirectorSell50,000$1.38$69,000.00View SEC Filing  
10/9/2017Moshe ShohamDirectorSell33,700$1.50$50,550.00View SEC Filing  
10/5/2017Yoseph BornsteinDirectorSell22,000$1.49$32,780.00View SEC Filing  
10/4/2017Yoseph BornsteinDirectorSell53,000$1.20$63,600.00View SEC Filing  
9/26/2017Yoseph BornsteinDirectorSell50,000$1.24$62,000.00View SEC Filing  
9/19/2017Yoseph BornsteinDirectorSell50,000$1.18$59,000.00View SEC Filing  
9/12/2017Yoseph BornsteinDirectorSell20,000$1.12$22,400.00View SEC Filing  
9/6/2017Yoseph BornsteinDirectorSell45,610$1.01$46,066.10View SEC Filing  
6/16/2017Leon LewkowiczMajor ShareholderSell71,224$1.67$118,944.083,078,214View SEC Filing  
12/29/2015Kenneth Blair StrattonGeneral CounselSell104,549$0.45$47,047.05556,525View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Microbot Medical (NASDAQ MBOT) News Headlines

Source:
DateHeadline
Head-To-Head Review: Microbot Medical (MBOT) vs. BioCryst Pharmaceuticals (BCRX)Head-To-Head Review: Microbot Medical (MBOT) vs. BioCryst Pharmaceuticals (BCRX)
www.americanbankingnews.com - May 26 at 3:12 AM
Microbot Medical Closes Acquisition of Novel Technology from CardioSert Ltd.Microbot Medical Closes Acquisition of Novel Technology from CardioSert Ltd.
feeds.benzinga.com - May 25 at 7:56 AM
BRIEF-Microbot Medical Announces Receiving Notification Of Granting Patent Right For Its VIRob Technology Platform ...BRIEF-Microbot Medical Announces Receiving Notification Of Granting Patent Right For Its VIRob Technology Platform ...
www.reuters.com - May 24 at 5:51 PM
Form 8-K Microbot Medical Inc. For: May 23Form 8-K Microbot Medical Inc. For: May 23
www.streetinsider.com - May 24 at 5:51 PM
Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob™ Technology Platform in ...Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob™ Technology Platform in ...
globenewswire.com - May 24 at 5:51 PM
Wired News - Microbot Medical Shares Results from the In-Vitro Study of its Self-Cleaning ShuntWired News - Microbot Medical Shares Results from the In-Vitro Study of its Self-Cleaning Shunt
finance.yahoo.com - May 23 at 8:12 AM
Microbot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob™ Technology Platform in ChinaMicrobot Medical Announces Receiving a Notification of Granting a Patent Right for its ViRob™ Technology Platform in China
finance.yahoo.com - May 23 at 8:12 AM
Microbot Medical Successfully Completes Pre-Clinical Study for its Self-Cleaning ShuntMicrobot Medical Successfully Completes Pre-Clinical Study for its Self-Cleaning Shunt
finance.yahoo.com - May 21 at 8:08 AM
Microbot Medical (MBOT) Announces Quarterly  Earnings Results, Beats Expectations By $0.01 EPSMicrobot Medical (MBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 16 at 7:12 PM
Is Microbot Medical Inc’s (NASDAQ:MBOT) CEO Salary Justified?Is Microbot Medical Inc’s (NASDAQ:MBOT) CEO Salary Justified?
finance.yahoo.com - May 16 at 8:08 AM
Microbot Medical (MBOT) Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt DeviceMicrobot Medical (MBOT) Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt Device
www.streetinsider.com - May 10 at 8:12 AM
Microbot Medical Announces Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt (SCS)™ DeviceMicrobot Medical Announces Receiving Notice of Allowance for a U.S. Patent covering its Self-Cleaning Shunt (SCS)™ Device
finance.yahoo.com - May 9 at 8:08 AM
Adverum Biotechnologies (ADVM) versus Microbot Medical (MBOT) Head to Head ContrastAdverum Biotechnologies (ADVM) versus Microbot Medical (MBOT) Head to Head Contrast
www.americanbankingnews.com - May 8 at 10:55 AM
Microbot Medical (MBOT) Rating Increased to Hold at ValuEngineMicrobot Medical (MBOT) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - May 3 at 12:10 AM
Stock Review for Medical Supplies Investors -- Insulet, Integra LifeSciences ...Stock Review for Medical Supplies Investors -- Insulet, Integra LifeSciences ...
www.prnewswire.com - May 2 at 5:44 PM
Stock Review for Medical Supplies Investors -- Insulet, Integra LifeSciences, Mazor Robotics, and Microbot MedicalStock Review for Medical Supplies Investors -- Insulet, Integra LifeSciences, Mazor Robotics, and Microbot Medical
www.bizjournals.com - May 2 at 8:12 AM
Microbot Medical Moves to State-of-the-Art Facility to Meet Next Phase of the Company’s Development EffortsMicrobot Medical Moves to State-of-the-Art Facility to Meet Next Phase of the Company’s Development Efforts
finance.yahoo.com - May 2 at 8:12 AM
MicroBot acquires endo-luminal technology from CardioSertMicroBot acquires endo-luminal technology from CardioSert
seekingalpha.com - April 16 at 5:34 PM
Microbot Medical Exercises Option to Acquire Novel Technology from CardioSert Ltd.Microbot Medical Exercises Option to Acquire Novel Technology from CardioSert Ltd.
finance.yahoo.com - April 16 at 5:34 PM
BRIEF-Microbot Medical Expects To Reach Development Milestones For Self Cleaning Shunt In Late 2018 Or Early 2019BRIEF-Microbot Medical Expects To Reach Development Milestones For Self Cleaning Shunt In Late 2018 Or Early 2019
www.reuters.com - April 14 at 8:12 AM
Microbot Medicals Self-Cleaning Shunt Awarded a Grant by the European CommissionMicrobot Medical's Self-Cleaning Shunt Awarded a Grant by the European Commission
globenewswire.com - April 14 at 8:12 AM
Microbot Medical (MBOT) and Mesoblast (MESO) Head to Head SurveyMicrobot Medical (MBOT) and Mesoblast (MESO) Head to Head Survey
www.americanbankingnews.com - April 7 at 5:23 AM
Microbot Medical Announces Appointment of Chief Technology OfficerMicrobot Medical Announces Appointment of Chief Technology Officer
finance.yahoo.com - April 5 at 5:25 PM
Microbot Medical (MBOT) Earns Buy Rating from Analysts at Ladenburg Thalmann Financial ServicesMicrobot Medical (MBOT) Earns Buy Rating from Analysts at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - March 26 at 10:59 AM
Pre-Market Technical Scan on Medical Supplies Equities -- Insulet, Integra LifeSciences, Mazor Robotics, and ... - PR Newswire (press release)Pre-Market Technical Scan on Medical Supplies Equities -- Insulet, Integra LifeSciences, Mazor Robotics, and ... - PR Newswire (press release)
www.prnewswire.com - March 23 at 8:11 AM
Critical Review: Dermira (DERM) vs. Microbot Medical (MBOT)Critical Review: Dermira (DERM) vs. Microbot Medical (MBOT)
www.americanbankingnews.com - February 25 at 8:30 AM
Microbot Medical’s CEO to Speak as an Industry Expert at the YJP CEO Healthcare SymposiumMicrobot Medical’s CEO to Speak as an Industry Expert at the YJP CEO Healthcare Symposium
finance.yahoo.com - February 13 at 8:46 AM
Microbot Medical (MBOT) Upgraded at ValuEngineMicrobot Medical (MBOT) Upgraded at ValuEngine
www.americanbankingnews.com - February 4 at 10:48 PM
Microbot Medical Inc. to Initiate Townhall MeetingsMicrobot Medical Inc. to Initiate Townhall Meetings
finance.yahoo.com - January 31 at 8:43 AM
Reviewing Microbot Medical (MBOT) & Its RivalsReviewing Microbot Medical (MBOT) & Its Rivals
www.americanbankingnews.com - January 21 at 3:24 AM
Insider Selling: Microbot Medical Inc (MBOT) Director Sells 35,000 Shares of StockInsider Selling: Microbot Medical Inc (MBOT) Director Sells 35,000 Shares of Stock
www.americanbankingnews.com - January 10 at 8:34 PM
Microbot Medical Enters into Agreement to Acquire Novel ... - GlobeNewswire (press release)Microbot Medical Enters into Agreement to Acquire Novel ... - GlobeNewswire (press release)
globenewswire.com - January 8 at 9:33 AM
Yoseph Bornstein Sells 42,132 Shares of Microbot Medical Inc (MBOT) StockYoseph Bornstein Sells 42,132 Shares of Microbot Medical Inc (MBOT) Stock
www.americanbankingnews.com - January 3 at 3:30 PM
Microbot Medical Inc (MBOT) Director Yoseph Bornstein Sells 14,257 SharesMicrobot Medical Inc (MBOT) Director Yoseph Bornstein Sells 14,257 Shares
www.americanbankingnews.com - December 28 at 5:56 PM
Microbot Medical Inc (MBOT) Director Sells $33,029.01 in StockMicrobot Medical Inc (MBOT) Director Sells $33,029.01 in Stock
www.americanbankingnews.com - December 21 at 5:52 PM
Financial Analysis: Bio Blast Pharma (ORPN) & Microbot Medical (MBOT)Financial Analysis: Bio Blast Pharma (ORPN) & Microbot Medical (MBOT)
www.americanbankingnews.com - December 14 at 1:28 PM
Microbot Receives Notice of Allowance for U.S. Patent Covering its TipCAT Technology PlatformMicrobot Receives Notice of Allowance for U.S. Patent Covering its TipCAT Technology Platform
feeds.benzinga.com - December 14 at 7:52 AM
Microbot Medical Inc (MBOT) Director Yoseph Bornstein Sells 44,159 SharesMicrobot Medical Inc (MBOT) Director Yoseph Bornstein Sells 44,159 Shares
www.americanbankingnews.com - December 13 at 6:40 PM
P. (Laxmin) Laxminarain Appointed to Microbot Medicals Board of Directors - GlobeNewswire (press release)P. (Laxmin) Laxminarain Appointed to Microbot Medical's Board of Directors - GlobeNewswire (press release)
globenewswire.com - December 13 at 10:06 AM
Yoseph Bornstein Sells 15,375 Shares of Microbot Medical Inc (MBOT) StockYoseph Bornstein Sells 15,375 Shares of Microbot Medical Inc (MBOT) Stock
www.americanbankingnews.com - December 7 at 9:32 PM
Aldeyra Therapeutics (ALDX) vs. Microbot Medical (MBOT) Head-To-Head ComparisonAldeyra Therapeutics (ALDX) vs. Microbot Medical (MBOT) Head-To-Head Comparison
www.americanbankingnews.com - December 7 at 7:28 PM
Is Microbot Medical Inc’s (MBOT) CEO Pay Justified?Is Microbot Medical Inc’s (MBOT) CEO Pay Justified?
finance.yahoo.com - December 6 at 5:06 PM
Yoav Zvi Waizer Acquires 10,000 Shares of Microbot Medical Inc (MBOT) StockYoav Zvi Waizer Acquires 10,000 Shares of Microbot Medical Inc (MBOT) Stock
www.americanbankingnews.com - December 6 at 3:00 PM
Microbot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 45,000 SharesMicrobot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 45,000 Shares
www.americanbankingnews.com - November 29 at 8:46 PM
Insider Selling: Microbot Medical Inc. (MBOT) Director Sells 45,000 Shares of StockInsider Selling: Microbot Medical Inc. (MBOT) Director Sells 45,000 Shares of Stock
www.americanbankingnews.com - November 29 at 8:46 PM
Microbot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning Shunt - GlobeNewswire (press release)Microbot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning Shunt - GlobeNewswire (press release)
globenewswire.com - November 8 at 4:56 PM
Microbot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning ShuntMicrobot Medical Inc. Receives Additional Government Grant for Development of its Self-Cleaning Shunt
finance.yahoo.com - November 8 at 4:56 PM
Microbot Medical Inc. (MBOT) Director Sells $57,000.00 in StockMicrobot Medical Inc. (MBOT) Director Sells $57,000.00 in Stock
www.americanbankingnews.com - October 26 at 2:30 PM
Microbot Medical Inc. (MBOT) Director Sells $58,000.00 in StockMicrobot Medical Inc. (MBOT) Director Sells $58,000.00 in Stock
www.americanbankingnews.com - October 25 at 5:45 PM
Microbot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 50,000 SharesMicrobot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 50,000 Shares
www.americanbankingnews.com - October 11 at 8:16 PM

SEC Filings

Microbot Medical (NASDAQ:MBOT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Microbot Medical (NASDAQ:MBOT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Microbot Medical (NASDAQ MBOT) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.